Urine Bacteria in Bladder Cancer vs. Other Conditions
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study compares the bacteria in urine of men with bladder cancer to those with other urinary issues and healthy men. For bladder cancer patients, it looks at differences before a planned surgery to remove the bladder.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with bladder cancer (urothelial carcinoma).
- You must have a negative urine culture (no current infection).
- You must be scheduled to have your bladder removed (radical cystectomy).
- You cannot have had BCG therapy for bladder cancer before.
- You cannot have taken antibiotics in the last two months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks if doing a urine culture before bladder tumor surgery can help prevent fever from urinary tract infections after surgery. It compares two ways of managing pre-surgery urine testing to see which is more effective in reducing post-surgery infection risks.
This study follows people with urothelial cancer and certain rare genital (genitourinary) cancers over time to learn how these diseases progress. It may help researchers understand patterns of symptoms and outcomes, even if it is not a drug trial.
This observational study follows people after surgery to remove the bladder to learn how often infections happen and what they look like. It may help doctors better prevent and manage complications after this operation.
This study looks at urothelial cancer (often bladder cancer) samples taken during diagnosis or standard treatment. It may help researchers better understand the disease by using tissue that doctors already need to collect for care.
This study tests a new non-invasive urine test (Xpert Bladder Monitor) to see if it can catch bladder cancer coming back early, reducing the need for frequent cystoscopy. It is for people with high-grade or high-risk non-muscle invasive bladder cancer who have had or are still having BCG treatment.
This study examines immune cells and tissue structure in bladder cancer samples from patients who had bladder removal surgery. Researchers hope to better understand how the immune system interacts with cancer tissue to improve future treatment strategies.
Hear when a new Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.